Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sakshi Luthra"'
Publikováno v:
Frontiers in Microbiology, Vol 9 (2018)
The incidence and prevalence of non-tuberculous mycobacterial (NTM) infections have been increasing worldwide and lately led to an emerging public health problem. Among rapidly growing NTM, Mycobacterium abscessus is the most pathogenic and drug resi
Externí odkaz:
https://doaj.org/article/b893c6e9c11046a49fbcf43db4c3d824
Autor:
Saman Hazany, Kim-Lien Nguyen, Martin Lee, Andrew Zhang, Parsa Mokhtar, Alexander Crossley, Sakshi Luthra, Pooja Butani, Sunita Dergalust, Benjamin Ellingson, Jason D. Hinman
Publikováno v:
Journal of Clinical Neuroscience. 105:131-136
Current methods for quantitative assessment of cerebral small vessel disease (CSVD) ignore critical aspects of the disease, namely lesion type and regionality. We developed and tested a new scoring system for CSVD, "regional Cerebral Small Vessel Dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a956150c6d6b4c750351109383e6633
https://doi.org/10.1016/j.jocn.2022.09.014
https://doi.org/10.1016/j.jocn.2022.09.014
Autor:
Sakshi Luthra, Aron Gagliardi, Daniel Schäfle, Peter Sander, Bettina Schulthess, Petra Selchow
Publikováno v:
Antimicrob Agents Chemother
Isoniazid (INH) is a cornerstone of antitubercular therapy. Mycobacterium tuberculosis complex bacteria are the only mycobacteria sensitive to clinically relevant concentrations of INH. All other mycobacteria, including M. marinum and M. avium subsp.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1102569a72ccde17372caab035c30af6
https://europepmc.org/articles/PMC7179591/
https://europepmc.org/articles/PMC7179591/
Autor:
Melisa Kamali-Grigorian, Sakshi Luthra, Sunita Dergalust, Neal M Rao, Jason D Hinman, Alexander Crossley, Hyojin C Suh, Naomi Wu, Jeremy Liu, Pooja B Butani, Roi Ann Wallis
Publikováno v:
Stroke. 51
Introduction: Recurrent strokes make up 25% of the annual stroke incidence with 10% of the Veteran population suffering a recurrent stroke within 1 year. The role of adherence to a post-stroke medication regimen and its effect on stroke recurrence is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a75c36d9da7617637e240faec4796598
https://doi.org/10.1161/str.51.suppl_1.tp419
https://doi.org/10.1161/str.51.suppl_1.tp419